Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
Sponsor: AlphaNet
A PHASE4 clinical study on Chronic Obstructive Pulmonary Disease (COPD), this trial is completed. The trial is conducted by AlphaNet and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Nov 2019 — Jan 2021 [monthly]
Completed PHASE4
-
Sep 2018 — Nov 2019 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
▶ Show 2 earlier versions
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AlphaNet
- American Association for Respiratory Care
- Apria Healthcare
- COPD Foundation
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- National Jewish Health
- Patient-Centered Outcomes Research Institute
- University of Illinois at Chicago
For direct contact, visit the study record on ClinicalTrials.gov .